Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda.
about
Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic reviewEffect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan AfricaNational policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and LinksHigh T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort.Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in Uganda.Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.Trends in prevalence of diarrhoea, Kaposi's sarcoma, bacterial pneumonia, malaria and geohelminths among HIV positive individuals in Uganda.The Medical Research Council (UK)/Uganda Virus Research Institute Uganda Research Unit on AIDS--'25 years of research through partnerships'.Morbidity among HIV-1-infected mothers in Kenya: prevalence and correlates of illness during 2-year postpartum follow-upAntiretroviral Treatment Scale-Up and Tuberculosis Mortality in High TB/HIV Burden Countries: An Econometric Analysis.Challenges facing effective implementation of co-trimoxazole prophylaxis in children born to HIV-infected mothers in the public health facilities.Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study.Human immunodeficiency virus (HIV) in developing countries.Impact of cotrimoxazole and insecticide-treated nets for malaria prevention on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review.Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled studyInvasive non-Typhi Salmonella disease in Africa.The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected womenEvaluation of Paracheck-Pf(TM) rapid malaria diagnostic test for the diagnosis of malaria among HIV-positive patients in Ibadan, south-western Nigeria.Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy.Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.
P2860
Q28084544-63040FE7-80D0-4978-9267-7D8B1143449DQ28084902-1886C868-79D9-4E27-B0BF-15D740F600D3Q30501533-0197692A-8564-42E5-81BC-BEE618035FD7Q30999041-A1EABAA5-3708-4EBE-86BF-322AEDDCA285Q33793347-EA05889B-BFD6-4ED9-A8FA-DB21F489B67EQ33851271-FB112AC0-71F1-4A3F-9461-77916D50A0BFQ34764823-683D588E-F50B-48B0-B3AE-0F092023E5C2Q35207311-C386A122-EA5F-4DB8-BFF2-8829EA2F1684Q35737444-5274A5B5-415A-49A2-A5F5-EA9610EC07C7Q35929458-7533464E-8004-45BF-8F9D-7573F40B93BDQ36023789-8FEECA46-C374-452A-A577-53270919CF90Q36106589-19D47822-24A9-4FA5-B9A0-59A2E6C8794DQ36244235-0936D81E-AC94-4B62-92D3-3AA83EFFD80BQ36517673-5E28C8AF-D985-4498-AF93-313119C681ABQ36561178-1FB281DE-FD10-4546-80BC-ECDC1BB5EBFBQ36759511-C29E715E-FB9D-4A24-AE04-3BC26E647651Q37097177-6831EF3D-44F0-4B68-B4C9-59045B55674DQ37341474-9ABF24FA-C123-4A8C-A092-423C54DDCF81Q37398249-572991A7-016F-4959-BD88-E1B385DBAD9BQ37726524-94371EEB-22C6-4309-9805-D00231B5F0BCQ38876857-E78FC703-3116-4A6A-AA13-CE0F2759F513Q40375985-C621831D-BD27-4829-8A43-9B6D0E0C0B22
P2860
Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Feasibility and effectiveness ...... an HIV/AIDS clinic in Uganda.
@en
type
label
Feasibility and effectiveness ...... an HIV/AIDS clinic in Uganda.
@en
prefLabel
Feasibility and effectiveness ...... an HIV/AIDS clinic in Uganda.
@en
P2093
P50
P1476
Feasibility and effectiveness ...... an HIV/AIDS clinic in Uganda.
@en
P2093
Anne Brink
Christine Watera
George Miiro
James Whitworth
Jonathan Mermin
Lucy Antvelink
Richard Muwonge
P304
P356
10.1097/01.QAI.0000221679.14445.1B
P407
P577
2006-07-01T00:00:00Z